 "Sohini Das")
Sohini Das
Sohini Das
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Page 18 - Sohini Das
How Wockhardt's bet on multi-drug resistant infections is paying off
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed
 "How Wockhardt's bet on multi-drug resistant infections is paying off")
US CDMO business seeing softening, says Piramal Pharma Chairperson
US biotech funding slowdown hits Piramal's CDMO business as company expands sterile injectables facility and maintains long-term growth targets
 "US CDMO business seeing softening, says Piramal Pharma Chairperson")
Shailesh Jejurikar becomes first Indian to lead 187-year-old P&G
Chief operating officer of consumer goods conglomerate will succeed Jon Moeller
 "Shailesh Jejurikar becomes first Indian to lead 187-year-old P&G")
Battle for ownership brews at Sona BLW after Sunjay Kapur's death
Firm proceeds with AGM despite objections from Kapur's mother
 "Battle for ownership brews at Sona BLW after Sunjay Kapur's death")
Govt to closely monitor price hikes of drugs outside essential list
The NPPA will ensure drug companies do not exceed the 10% annual price increase limit on non-essential medicines
 "Govt to closely monitor price hikes of drugs outside essential list")
India-UK trade deal: Smooth road ahead as luxury cars set to get cheaper
Under the FTA, tariffs on automotive imports will come down by 50 per cent over 10 years (out of quota)
 "India-UK trade deal: Smooth road ahead as luxury cars set to get cheaper")
India-UK trade deal: Med device firms cautious about country of origin
The UK-India Free Trade Agreement is expected to boost trade in pharmaceuticals and medical devices, though industry players remain cautious about the impact of country of origin rules
 "India-UK trade deal: Med device firms cautious about country of origin")
Maruti Fronx tops SUV exports in FY25, clocks 100,000 units in 25 months
Fronx drives Maruti Suzuki's record FY25 exports with 69,000 units shipped globally, becoming the fastest SUV to cross 100,000 units in overseas sales
 "Maruti Fronx tops SUV exports in FY25, clocks 100,000 units in 25 months")
Renault eyes full capacity at Chennai plant, no new partner planned
In a major product launch from Renault in five years, the company on Wednesday launched a next-generation Triber priced attractively between ₹6.2 lakh and ₹8.4 lakh
 "Renault eyes full capacity at Chennai plant, no new partner planned")
Results preview: Pharma firms stare at muted earnings growth for Q1
Hospitals have a steady quarter with occupancies rising 100 bps
 "Results preview: Pharma firms stare at muted earnings growth for Q1")
EV giant Tesla's India entry may have more symbolic than strategic value
Many see Tesla's India entry as an attempt to address the capacity glut at its global plants, from where excess inventory might be brought to India
 "EV giant Tesla's India entry may have more symbolic than strategic value")
Tesla rolls out Model Y in India, costlier than US, China and Germany
Tesla opens bookings for Model Y in India at up to ₹67.89 lakh due to high import duties, with first deliveries expected later in 2025 from Shanghai plant
 "Tesla rolls out Model Y in India, costlier than US, China and Germany")
Q1 results preview: Low volumes, discounts may have dented auto margins
Downside risks from rare-earth magnets an overhang for the sector
 "Q1 results preview: Low volumes, discounts may have dented auto margins")
Valuation of Manipal Hospitals hits $13 billion; firm eyes IPO in 2026
Bengaluru-based Manipal Hospitals cements top spot with major expansion, aims IPO
 "Valuation of Manipal Hospitals hits $13 billion; firm eyes IPO in 2026")
Glenmark arm inks $700 million licensing deal with US-based AbbVie
IGI Therapeutics, a wholly owned subsidiary of Glenmark, has licensed its cancer and autoimmune drug ISB 2001 to AbbVie for an upfront payment of $700 million
 "Glenmark arm inks $700 million licensing deal with US-based AbbVie")
No immediate production impact due to rare-earth crunch: JSW MG Motor
Company says parts pipeline remains steady for now as orders placed in April are arriving; rare-earth supply disruption remains under close watch for future impact
 "No immediate production impact due to rare-earth crunch: JSW MG Motor")
India's pharma exports to US surged in March amid tariff concerns
India's pharma exports saw a significant rise in March, driven by fears of impending US tariffs. Industry experts anticipate impact of potential reciprocal tariffs on India's future export strategy
Apollo AyurVAID aims for 1,000 beds by 2028, eyes ₹500 crore turnover
Apollo AyurVAID, one of India's largest Ayurvedic hospital chains, targets 1,000 beds and Rs 500 crore turnover by 2028, as demand for Ayurvedic treatments rises
 "Apollo AyurVAID aims for 1,000 beds by 2028, eyes ₹500 crore turnover")
Car price inflation may moderate 4.5% over 5 years as tech improves
While average selling prices rose 7.6% between 2019 and 2024 due to premiumisation and regulation costs, they are expected to rise more moderately at 4.5% CAGR till 2029
 "Car price inflation may moderate 4.5% over 5 years as tech improves")
Luxury cars' share in EV sales up as uber rich shift to clean fuel
India's ultra-rich are embracing EVs, with the luxury electric segment growing 66% in 2025; Mercedes, BMW, Audi lead, aided by new launches and better charging infra
 "Luxury cars' share in EV sales up as uber rich shift to clean fuel")